Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-08 5:16 pm Sale | 13G | AYALA PHARMACEUTICALS INC AYLA | Redmile Group LLC | 0 0% | -1,472,522 (Position Closed) | View |
| 2023-02-07 06:01 am Purchase | 13G | ADVAXIS INC PAR $0.001 ADXS | Harel Insurance Investments & Financial Services Ltd. | 403,523 8.3% | 403,523 (New Position) | View |
| 2023-02-06 2:49 pm Sale | 13G | AYALA PHARMACEUTICALS INC AYLA | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -710,235 (Position Closed) | View |
| 2023-01-23 4:29 pm Sale | 13G | AYALA PHARMACEUTICALS INC AYLA | Schindel Yair Chaim | 0 0% | -2,991,473 (Position Closed) | View |
| 2023-01-09 06:51 am Unchanged | 13G | AYALA PHARMACEUTICALS INC AYLA | Schindel Yair Chaim | 2,991,473 20.18% | 0 (Unchanged) | View |
| 2022-10-31 4:00 pm Unchanged | 13G | AYALA PHARMACEUTICALS INC AYLA | Novartis Institutes for BioMedical Research Inc. | 698,777 4.7% | 0 (Unchanged) | View |
| 2022-02-14 5:07 pm Purchase | 13G | AYALA PHARMACEUTICALS INC AYLA | Redmile Group LLC | 1,472,522 9.9% | 91,445 (+6.62%) | View |
| 2022-02-04 09:15 am Sale | 13G | AYALA PHARMACEUTICALS INC AYLA | WELLINGTON MANAGEMENT GROUP LLP | 710,235 5.1% | -45,120 (-5.97%) | View |
| 2022-01-31 10:58 am Sale | 13G | AYALA PHARMACEUTICALS INC AYLA | Harel Insurance Investments & Financial Services Ltd. | 2,153,272 15.5% | -10,562 (-0.49%) | View |
| 2022-01-24 06:10 am Unchanged | 13G | AYALA PHARMACEUTICALS INC AYLA | Schindel Yair Chaim | 2,991,473 21.47% | 0 (Unchanged) | View |
| 2021-03-02 4:10 pm Purchase | 13G | AYALA PHARMACEUTICALS INC AYLA | Redmile Group LLC | 1,381,077 9.99% | 713,261 (+106.81%) | View |
| 2021-02-16 4:06 pm Purchase | 13G | AYALA PHARMACEUTICALS INC AYLA | Redmile Group LLC | 667,816 5.2% | 667,816 (New Position) | View |
| 2021-02-08 1:54 pm Purchase | 13G | AYALA PHARMACEUTICALS INC AYLA | Israel Biotech Fund I L.P. | 3,315,119 25.9% | 3,315,119 (New Position) | View |
| 2021-02-08 06:01 am Purchase | 13G | AYALA PHARMACEUTICALS INC AYLA | Schindel Yair Chaim | 2,991,473 23.41% | 2,991,473 (New Position) | View |
| 2021-02-05 5:17 pm Purchase | 13G | AYALA PHARMACEUTICALS INC AYLA | Novartis Institutes for BioMedical Research Inc. | 698,777 5.5% | 698,777 (New Position) | View |
| 2021-02-03 2:14 pm Purchase | 13G | AYALA PHARMACEUTICALS INC AYLA | WELLINGTON MANAGEMENT GROUP LLP | 755,355 5.91% | 755,355 (New Position) | View |
| 2020-05-14 8:30 pm Purchase | 13G | AYALA PHARMACEUTICALS INC AYLA | Harel Insurance Investments & Financial Services Ltd. | 2,163,834 17.4% | 2,163,834 (New Position) | View |